GWA
BIIB icon

GGM Wealth Advisors’s Biogen BIIB Stock Holding History

GGM Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,290
Closed -$316K – 133
2023
Q4 		$316K Hold
1,290
– – 0.13% 113
2023
Q3 		$332K Hold
1,290
– – 0.14% 98
2023
Q2 		$361K Buy
+1,290
New +$384K 0.15% 94
2023
Q1 		– Sell
-1,290
Closed -$360K – 70
2022
Q4 		$360K Hold
1,290
– – 0.19% 86
2022
Q3 		$352K Buy
1,290
+20
+2% +$4.25K 0.19% 88
2022
Q2 		$273K Hold
1,270
– – 0.15% 108
2022
Q1 		$283K Buy
+1,270
New +$276K 0.14% 116

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GGM Wealth Advisors's BIIB Position: Q1 2024 in Review

GGM Wealth Advisors sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,290 shares — an estimated $316K sold.

GGM Wealth Advisors first reported a position in BIIB in Q1 2022 and held it in 7 quarters. The position peaked at $361K in Q2 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • GGM Wealth Advisors reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • GGM Wealth Advisors sold 1,290 Biogen shares in Q1 2024, an estimated $316K.
  • GGM Wealth Advisors first reported a position in Biogen in Q1 2022 and held it in 7 quarters.
  • GGM Wealth Advisors's Biogen position peaked at $361K in Q2 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on GGM Wealth Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.